Bioactive Peptide Market Synopsis:
\nBioactive Peptide Market Size Was Valued at USD 2,509.5 Million in 2023, and is Projected to Reach USD 4,063.12 Million by 2032, Growing at a CAGR of 5.5% From 2024-2032.
\nBioactive Peptide Market refers to Bioactive peptides that are either ingested in foods or produced through biotechnological processes and have valuable therapeutic, nutraceutical, or cosmetic properties. From plants and animals, and microorganisms these peptides have uses such as antioxidant, antimicrobial, immunostimulant, and many others, thus being of uttermost importance in managing diseases of different natures, chronic, infection-related, or oxidative stress ones.
\nThe global market for Bioactive Peptide has been exhibiting decent growth in the recent past due to awareness among consumers about various health benefits associated with bioactive peptides as well as application in different industries. As multifunctional molecules with authentic capability to replace or supplement artificial medications, bioactive peptides feature extensively in pharmacology, nutraceuticals, and cosmetics. Increased incidences of chronic diseases due to their associated risk factors like diabetes, hypertension, and cardiovascular diseases have further enhanced the markets for bioactive peptides in therapeutic and prophylactic health care systems.
\nAlso, the market has sampled increased advances in the technology of synthesizing and extracting peptides making bioactive peptides more available and affordable to manufacturers. Some more factors have driven the opportunities in the market for pro-biotics, such as the expansion of functional food and nutraceuticals because conscious consumers looking for more of health enhancements. The technology simplification of bioactive peptides; coupled with continuous basic research to discover new uses, guarantees prospects in this marketplace. Although industry growth is apparent, some issues slow the market development including regulatory obstructions and inability to increase production.<\/p>\n
Bioactive Peptide Market Trend Analysis:
\nRising Adoption of Plant-Based Bioactive Peptides<\/p>\n
Bioactive Peptide Market is one of the key markets, where the ongoing paradigm shift towards plant-based solutions has been noted. Developing market trends towards Sustainability and Veganism have led many manufacturers to retrieve peptides from plant ingredients including soy, wheat, and beans. These plant-derived bioactive peptides are desirable due to their low allergenicity and their effects on minimal environmental impact. Moreover, growth in green extraction technologies that minimize environmental impacts has boosted this sector. With increasing global concern towards what is consumed, shifting diets, and the emerging world on sustainability, bioactive peptides derived from plants is therefore anticipated for great demand.
\nExpanding Applications in Functional Foods and Beverages<\/p>\n
Bioactive Peptide application in the functional food and beverages sector is one of the most promising segments for the Bioactive Peptide Market. As people pay more attention to the overall health, well-being and pushing for more effective and sustainable health products for disease prevention in the current market, customers are embracing food supplements higher in bioactive peptides for immune support, digestive health, and more. The following trend is very strong particularly in the old-age and high-disposable income countries. These delivery systems make it possible to use the bioactive peptides in a wide product variety and hence a wider market opportunity; such as drinks, snacks, and even dietary supplements.
\nBioactive Peptide Market Segment Analysis:
\nBioactive Peptide Market is segmented on the basis of source, therapeutic area, distribution channel, and region
\nBy Source, Plant segment is expected to dominate the market during the forecast period<\/p>\n
The Plant segment is expected to have a higher market share of Bioactive Peptide during the forecast period as it is easily available and people prefer to use Bioactive Peptide which has its origin from plant source. Endogenous biologically active plant-derived peptides which are mainly found in soy pulses and cereal protein show great potential in functional foods, nutraceuticals, and pharmaceutical companies because of their health effects like antioxidant and antihypertensive. Further, the increase in veganism and other environmental factors has increased the demand for plant bioactive peptides. These peptides are also not as closely monitored as animal-derived peptides because they do not harbour the same pathogens. Supported by recent developments in extraction methods and increasing interest in plant proteins this segment appears to be well positioned for further growth.
\nBy Therapeutic Area, the antimicrobial segment is expected to hold the largest share <\/p>\n
The Antimicrobial segment is expected to dominate the Bioactive Peptide Market since antimicrobial peptides (AMPs) are increasingly being used to prevent infection. These peptides which show action against a wide range of bacteria, viruses, and fungi are gradually assuming the role of helping out in the ever-increasing problem of antibiotic resistance. The main uses of AMPs are reported in pharmaceuticals, functional foods, and advanced healthcare sectors because of their bacteriostatic properties that do not encourage the emergence of resistant strains. The proliferation of infections, the need for natural preservation in food, and in the growth of this segment are propelled by those using natural antimicrobial agents in personal care products. Future advancements in the functionality and performance of AMPs are therefore likely to increase market domination by the type.
\nBioactive Peptide Market Regional Insights:
\nNorth America is Expected to Dominate the Market Over the Forecast period <\/p>\n
North America region is anticipated to have the largest share of the Bioactive Peptide Market over the forecast period mainly due to its well-developed life science and healthcare systems as well as focus on research activities. The region\u2019s well-established pharmaceutical industries with nutraceutical industries having made large investments in bioactive peptides\u2019 uses are driving factors. The US dominates this region due to its advanced technologies in building peptides, and a high incidence of diseases requiring novel treatment.<\/p>\n
The existence of numerous functional food producers and rising consumer knowledge of preventive health measures are factors positively impacting bioactive peptides demand in supplements and foods. Canada is another key region focusing on sustainability and natural products that APANA has in common with the current global push for plant-based bioactive peptides. The favorable regulatory policies and the region holding the largest number of approvals for peptide-based drugs also supports the growth of the North American market. This is in addition to the fact that North America is more engaging in combating antibiotic resistance hence the need to embrace antimicrobial peptides. Consumers in North America, especially those in the United States of America, enjoy relatively high disposable income and are very willing to spend their money-making products that are likely to improve their general health and wellbeing hence acting as a strong market for Bioactive Peptide.<\/p>\n
Active Key Players in the Bioactive Peptide Market<\/p>\n
Amgen Inc. (USA)<\/p>\n
AstraZeneca PLC (UK)<\/p>\n
BASF SE (Germany)<\/p>\n
BioGaia AB (Sweden)<\/p>\n
Danone S.A. (France)<\/p>\n
DuPont de Nemours, Inc. (USA)<\/p>\n
Glanbia PLC (Ireland)<\/p>\n
GlaxoSmithKline PLC (UK)<\/p>\n
Ingredion Incorporated (USA)<\/p>\n
Koninklijke DSM N.V. (Netherlands)<\/p>\n
Nestl\u00e9 S.A. (Switzerland)<\/p>\n
Novozymes A\/S (Denmark)<\/p>\n
Pfizer Inc. (USA)<\/p>\n
Reckitt Benckiser Group PLC (UK)<\/p>\n
Zymogenetics, Inc. (USA)<\/p>\n
Other Active Players
\nKey Industry Development in the Bioactive Peptide Market:<\/p>\n
In May 2024, UGM collaborated with the Institute of Agrochemistry and Food Technology (IATA) Spain to research bioactive peptides from goat collagen for health supplements. The partnership was led by Professor Yuny Erwanto from UGM\u2019s Faculty of Animal Science. Established in 1966, IATA is part of the Spanish National Research Council (CSIC) and specializes in agrochemistry and food technology. The collaboration began after frequent online lectures featuring IATA researcher Fidel Toldr\u00e1, whose expertise in bioactive peptides inspired Professor Erwanto to initiate joint research efforts.<\/p>\n
In January 2024, Invaio Sciences recently acquired Peptyde Bio, a company specializing in the discovery and design of novel peptides for agricultural use. The acquisition provided Invaio with a valuable platform and IP portfolio to enhance its development of biologically active peptides for sustainable crop protection. Known for creating nature-positive solutions, Invaio combined environmentally friendly active ingredients with advanced delivery systems. Their strategy focused on utilizing an AI-powered Discovery Engine to design targeted biological actives, addressing sustainability concerns in protecting vegetables, row crops, and perennials.<\/p>\n","protected":false},"excerpt":{"rendered":"
Bioactive Peptide Market refers to Bioactive peptides that are either ingested in foods or produced through biotechnological processes and have valuable therapeutic, nutraceutical, or cosmetic properties.<\/p>\n","protected":false},"featured_media":22638,"template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[194],"product_tag":[],"class_list":["post-25447","product","type-product","status-publish","has-post-thumbnail","product_cat-healthcare-life-sciences","first","instock","virtual","purchasable","product-type-simple"],"acf":[],"yoast_head":"\n